test

Jordan Stuart Pober MD, PhD

Bayer Professor of Translational Medicine; Director, Human and Translational Immunology Program; Vice-Chair, Dept. of Immunobiology for the Section of Human and Translational Immunology

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and Physiology

Stem Cell Center, Yale: Stem Cells and Tissue Repair | Tissue Specific Stem Cells

Cancer Immunology

Vascular Biology and Therapeutics Program

Immunobiology: HTI

Dermatology

Pathology

Diabetes Research Center

NIH T32 Program

Immunology and Immunotherapy


Research Interests

Immunobiology of vascular endothelial cells; Cytokine actions and mechanisms; Transplantation immunology  more...


Education

  • M.D., Yale University, 1977
  • Ph.D., Yale University, 1977

Selected Publications

  • Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells. Fogal B, Yi T, Wang C, Rao DA, Lebastchi A, Kulkarni S, Tellides G, Pober JS. J Immunol. 2011 Dec 15;187(12):6268-80. Epub 2011 Nov 14.
  • Participation of blood vessel cells in human adaptive immune responses. Pober JS, Tellides G. Trends Immunol. 2012 Jan;33(1):49-57. Epub 2011 Oct 24. Review.
  • Enis DR, Shepherd BR, Wang Y, Qasim A, Shanahan CM, Weissberg PL, Kashgarian M, Pober JS, Schechner JS. Induction, differentiation and remodeling of mature blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc Natl Acad Sci. (USA) 2005; 102:425-430.

more...

collapsible-single-column-one-thumbnailphotobooksupi=10264452/WCF/News.svc/

Latest News

3
more...

Edit Profile